Ronald Levy

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

SD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid Malignancies

First Posted Date
2019-02-05
Last Posted Date
2023-11-22
Lead Sponsor
Ronald Levy
Target Recruit Count
12
Registration Number
NCT03831295
Locations
🇺🇸

Stanford Cancer Institute Palo Alto, Palo Alto, California, United States

A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

First Posted Date
2009-04-14
Last Posted Date
2017-03-14
Lead Sponsor
Ronald Levy
Target Recruit Count
30
Registration Number
NCT00880581
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

First Posted Date
2007-06-22
Last Posted Date
2020-01-13
Lead Sponsor
Ronald Levy
Target Recruit Count
59
Registration Number
NCT00490529
Locations
🇺🇸

Stanford University Medical Center, Stanford, California, United States

CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas

Phase 1
Completed
Conditions
Interventions
First Posted Date
2005-09-16
Last Posted Date
2014-08-01
Lead Sponsor
Ronald Levy
Target Recruit Count
30
Registration Number
NCT00185965
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

© Copyright 2024. All Rights Reserved by MedPath